Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Panagiota Boura"'
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 6 (2015)
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of antihyperglycaemic agents with an insulin-independent mode of action. Dapagliflozin is a member of the SGLT2 inhibitors class that has received marketing authorization in Europe a
Externí odkaz:
https://doaj.org/article/edf49e626c334d7886c4a3aad9c17624
Autor:
Antonios Psarras, Ioannis Gkougkourelas, Konstantinos Tselios, Alexandros Sarantopoulos, Panagiota Boura
Publikováno v:
Case Reports in Rheumatology, Vol 2014 (2014)
Environmentally induced systemic sclerosis is a well-recognized condition, which is correlated with exposure to various chemical compounds or drugs. However, development of scleroderma-like disease after exposure to silicone has always been a controv
Externí odkaz:
https://doaj.org/article/057eea7400da4ba4aeb999234e1cebb0
Autor:
Efthymia Vlachaki, Panagiotis Andreadis, Nikolaos Neokleous, Aleka Agapidou, Evaggelia Vetsiou, Panagiotis Katsinelos, Panagiota Boura
Publikováno v:
Case Reports in Hematology, Vol 2014 (2014)
Sickle cell/β+ thalassemia (Hb S/β+thal) is considered as a variant form of sickle cell disease. Acute episodes of vasoocclusive pain crisis are characteristic for sickle cell disorders and may be complicated by an acute or chronic life-threatening
Externí odkaz:
https://doaj.org/article/30e4ca02d982438ebf001f59f17535fc
Publikováno v:
Clinical and Developmental Immunology, Vol 2008 (2008)
Chronic brucellosis patients display a defective Th1 response to PHA. We have previously shown that heat-killed B. abortus (HKBA) can downregulate the PHA-induced increase of CD4+/CD25+ and CD14+/CD80+ cells of brucellosis patients. In the present st
Externí odkaz:
https://doaj.org/article/45b78a1992d547ec84d90b38a1303565
Autor:
Panagiota Boura
Η παρούσα διατριβή είναι μια από τις λίγες μελέτες που έχει ως σκοπό τη διερεύνηση της επίδρασης των φορολογικών και άλλων δημοσιονομικ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf4439dedfdef3e2f86bac1312840ce
https://doi.org/10.12681/eadd/36794
https://doi.org/10.12681/eadd/36794
Publikováno v:
Journal of International Business and Management. :1-14
Firms, especially in economies in crisis, seek new ways to increase and exploit their competitive advantage and turn to export activity in order to limit their dependence on the domestic markets and achieve sustainability. In this paper, we are exami
Publikováno v:
Proceedings of the 11th Business & Management Conference, Dubai.
Even though most of the export benefits inter alia refer to high productivity and profitability, the question is whether these performance indicators have been improved solely as a result of export activity or not. As such, in this study, we investig
Autor:
Iakovos Avramidis, Nikolaos Tentolouris, George Dimitriadis, Kalliopi Kotsa, Panagiota Boura, Vaia Lambadiari, Spyridon Gerou, Apostolos Tsapas, Aris Liakos, Konstantinos Kitsios, Alexandra Bargiota
Publikováno v:
Diabetes, Obesity and Metabolism. 21:517-524
Aims To assess the effect of liraglutide on 24-hour ambulatory blood pressure and heart rate in patients with hypertension (pre- and stage 1 hypertension) and inadequately controlled Type 2 diabetes (glycated haemoglobin 7%-10% [53-86 mmol/mol]). Mat
Autor:
Panagiota Boura, Ioannis Gkougkourelas, M. Pantoura, Eleni Bekiari, Nikolaos Raptis, Apostolos I. Hatzitolios, Konstantinos Tselios, Alexandros Sarantopoulos, Konstantinos Tziomalos, Evangelia Makri
Publikováno v:
Rheumatology International. 37:293-298
Systemic lupus erythematosus (SLE) is associated with increased cardiovascular risk. We aimed to evaluate arterial stiffness and the ankle brachial index (ABI), two markers of subclinical cardiovascular disease, in SLE. We studied 55 patients with SL
Autor:
Dimitrios Karokis, Panagiota Boura, Katerina Laskari, Alexandros Garyfallos, Elena Tsitsami, George N. Dalekos, Dimitrios Pikazis, Grigoris Skarantavos, Loukas Settas, Petros P. Sfikakis
Publikováno v:
The Journal of Rheumatology. 44:102-109
Objective.To assess the efficacy and safety of the interleukin-1β (IL-1β) inhibitor canakinumab in all adolescent and adult patients with familial Mediterranean fever (FMF) identified from the Greek National Registry for off-label drug use between